GO:0106301 arachidonate 5,6-epoxygenase activity

Arachidonate 5,6-epoxygenase activity (GO:0106301) is a molecular function defined as the catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-5,6-epoxyeicosatrienoic acid (5,6-EET). This activity sits within the cytochrome P450 epoxygenase arm of arachidonic acid metabolism, a branch that produces epoxyeicosatrienoic acids (EETs) as bioactive lipid mediators. Because 5,6-EET is a regioisomer with distinct chemical behavior, its formation and downstream conversion are of interest to researchers studying lipid signaling, vascular biology, and inflammatory pathways. The product 5,6-EET is unstable and undergoes hydration to 5,6-dihydroxyeicosatrienoic acid (5,6-DHET), which can further cyclize to 5,6-dihydroxyeicosatrienoate-1,5-lactone. This lactone has been detected in tissue homogenates using high-performance liquid chromatography-thermospray mass spectrometry, providing a practical analytical handle on 5,6-epoxygenase pathway output. Such measurements allow investigators to link enzyme activity to physiological and pathological states. For gene-editing researchers, GO:0106301 offers a defined enzymatic endpoint to interrogate with CRISPR models. Knockout, point-mutation, knock-in, and overexpression strategies can be paired with metabolite profiling to test whether candidate genes are necessary or sufficient for 5,6-EET production. This article summarizes the definition, mechanism, key genes, disease relevance, and research methods for arachidonate 5,6-epoxygenase activity, with all factual statements anchored to the verified literature.

In practical terms, arachidonate 5,6-epoxygenase activity is the capacity of an enzyme to use NADPH and molecular oxygen to insert a single oxygen atom into arachidonic acid at the 5,6 double bond, yielding cis-5,6-epoxyeicosatrienoic acid. The term is a molecular function in the Gene Ontology and is synonymous with arachidonic acid 5,6-epoxygenase activity. It is distinguished from other arachidonate epoxygenase activities by the specific position of epoxidation on the fatty acid chain. The reaction is part of the broader epoxygenase pathway that generates EETs, and its product can be further metabolized to 5,6-DHET and the corresponding lactone.

Arachidonate 5,6-epoxygenase activity matters because it defines a specific enzymatic route to 5,6-EET, a lipid mediator whose formation and subsequent conversion can be measured in biological samples. The ability to detect the stable lactone derivative of 5,6-DHET by HPLC-thermospray mass spectrometry gives researchers a concrete analytical target for assessing pathway activity in tissue homogenates. This is essential for linking candidate genes to actual metabolite output rather than inferring function from expression alone. In gene-editing workflows, GO:0106301 provides a functional endpoint that can validate knockout, point-mutation, knock-in, or overexpression models.

The following genes and proteins are relevant to arachidonate 5,6-epoxygenase activity and its analytical detection, based on the verified literature.

The verified literature does not provide specific regulatory mechanisms for arachidonate 5,6-epoxygenase activity beyond its dependence on NADPH and oxygen. Regulation may occur at the level of substrate availability, cofactor supply, and enzyme expression, but these are not detailed in the cited source. Researchers should consult additional primary literature for pathway-specific regulatory data.

Arachidonate 5,6-epoxygenase activity produces 5,6-EET, a lipid mediator that can be further converted to 5,6-DHET and its lactone. Detection of these metabolites in tissue homogenates supports research into how this pathway operates in different physiological contexts. While the cited study focuses on analytical methodology, it provides a foundation for investigating disease associations through metabolite measurement.

The ability to measure 5,6-dihydroxyeicosatrienoate-1,5-lactone by HPLC-thermospray mass spectrometry offers a potential biomarker readout for 5,6-epoxygenase pathway activity. Such readouts could be applied in studies of inflammatory or vascular conditions where arachidonic acid metabolites are implicated, although the cited source does not establish specific disease links. This highlights the need for further research to connect GO:0106301 activity to clinical phenotypes.

High-performance liquid chromatography-thermospray mass spectrometry has been used to detect 5,6-dihydroxyeicosatrienoate-1,5-lactone from tissue homogenates. This method provides a direct analytical readout of the 5,6-epoxygenase pathway product. It is suitable for validating gene-edited models where pathway flux is expected to change.

The cited method analyzes tissue homogenates, which serve as the biological matrix for detecting the lactone metabolite. Proper homogenization and sample handling are critical for preserving labile lipid metabolites. This approach can be adapted to cultured cells or animal tissues in gene-editing studies.

Measuring 5,6-DHET and its lactone allows researchers to infer upstream 5,6-epoxygenase activity. Combining this with genetic perturbations enables causal inference about specific genes. The method is compatible with comparative studies across genotypes.

CRISPR library screening can be paired with metabolite detection to identify genes that regulate 5,6-epoxygenase activity. This combines genetic perturbation with analytical chemistry for functional genomics. The cited analytical method provides the endpoint for such screens.

Researchers studying arachidonate 5,6-epoxygenase activity-related genes often need to determine whether a candidate gene is causally involved in 5,6-EET production or its downstream metabolism. This requires robust genetic models paired with reliable metabolite detection. EDITGENE provides CRISPR-based services to generate such models and support functional validation.

Arachidonate 5,6-epoxygenase activity (GO:0106301) is a defined molecular function that converts arachidonic acid to cis-5,6-epoxyeicosatrienoic acid in an NADPH- and oxygen-dependent manner. Its product and downstream metabolites, including 5,6-dihydroxyeicosatrienoate-1,5-lactone, can be detected by HPLC-thermospray mass spectrometry in tissue homogenates. This provides a practical readout for researchers investigating the epoxygenase branch of arachidonic acid metabolism. CRISPR-based gene editing offers powerful tools to test the roles of specific genes in this pathway. By combining knockout, point-mutation, knock-in, and overexpression models with metabolite profiling, researchers can establish causal links between genes and 5,6-epoxygenase activity. EDITGENE provides these services to accelerate discovery in lipid signaling research.